$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Brigatinib/Brigatinib vs. Lorlatinib: Comparison of Two ALK Inhibitors
2026-02-01 22:25:32
Check Details
Brigatinib/Brigatinib vs. Osimertinib: An in-depth comparison of two lung cancer drugs
2026-02-01 22:25:32
Check Details
Brigatinib/Brigatinib treatment cost detailed: How much does it cost per month
2026-02-01 22:25:32
Check Details
Estimated launch time of brigatinib/brigatinib in China
2026-02-01 22:25:32
Check Details
Brigatinib/Brigatinib usage and dosage
2026-02-01 22:25:32
Check Details
How often should you take brigatinib/brigatinib?
2026-02-01 22:25:32
Check Details
Clinical Data for Brigatinib/Brigatinib
2026-02-01 22:25:32
Check Details
Specifications of brigatinib/brigatinib
2026-02-01 22:25:32
Check Details
Has brigatinib/brigatinib been launched in China?
2026-02-01 22:25:32
Check Details
Brigatinib/Brigatinib Usage Guidelines and Dosage Adjustments
2026-02-01 22:25:32
Check Details
Frequency and precautions for taking brigatinib/brigatinib
2026-02-01 22:25:32
Check Details
Clinical manifestations and pharmacokinetic properties of brigatinib/brigatinib
2026-02-01 22:25:32
Check Details
1
2
...
651
652
653
654
655
656
657
...
10211
10212
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Complete Guide to Dosage and Dose Adjustment of Entrectinib
2
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
3
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
4
Sopyrronium Bromide (Sofdra) for Hyperhidrosis: Uses, Mechanism and Facial Application Risks
5
Optimal Dosing Time and Medication Principles of Vigabatrin (Sabril)
6
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
7
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
8
Cabotegravir Sodium: Pioneering Long-Acting Solution for HIV Treatment and Prevention
9
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
10
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
11
Opicapone Contraindications: Essential Restrictions for At-Risk Groups
12
Finerenone: An Innovative Treatment for Diabetic Kidney Disease